Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3034

Actual shortage: 241 (8%)
Anticipated shortage: 18 (1%)
Avoided shortage: 9 (0%)
Resolved: 2766 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

30 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-05-31 2019-05-31 50971
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2022-05-16 86341
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2019-07-02 86347
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-07-17 2020-07-10 89554
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-09-18 2019-11-16 94203
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2020-05-08 2021-03-09 114327
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2022-09-01 2022-11-20 168353
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2022-12-09 2023-01-13 177618
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Actual shortage 2023-05-12 2023-09-01 192361
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Actual shortage 2023-06-23 2023-09-01 196306
APO-PROCAINAMIDE CAP 375MG 375G CAPSULE Actual shortage 2017-08-13 2017-10-05 18979
APO-CEFACLOR 375MG POWDER Actual shortage 2017-08-13 2017-10-05 19072
APO-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2018-02-21 2018-08-09 40354
APO-NAPROXEN 375MG TABLET Resolved 2018-02-26 2018-07-18 41142
APO-NAPROXEN 375MG TABLET Resolved 2018-11-30 2018-12-21 68228
APO-NAPROXEN 375MG TABLET Resolved 2018-12-12 2018-12-21 69312
APO-NAPROXEN 375MG TABLET Resolved 2020-01-22 2020-02-21 103914
APO-NAPROXEN 375MG TABLET Resolved 2020-02-05 2020-02-21 105352
APO-NAPROXEN 375MG TABLET Resolved 2021-02-05 2021-03-30 133385
APO-NAPROXEN 375MG TABLET Resolved 2021-02-19 2021-03-17 134439

Showing 1961 to 1980 of 3034

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DONEPEZIL 5MG TABLET Discontinued 2018-09-07 2019-02-13 60453
APO-ENALAPRIL 5MG TABLET Discontinued 2018-09-07 2018-11-02 60468
APO GLYBURIDE TAB 5MG 5MG TABLET Discontinued 2018-09-07 2018-12-14 60518
APO-LISINOPRIL 5MG TABLET Discontinued 2018-09-07 2019-02-13 60585
APO PREDNISONE TAB 5MG 5MG TABLET Discontinued 2018-09-08 2018-12-28 60699
APO-ROSUVASTATIN 5MG TABLET Discontinued 2018-09-08 2018-09-15 60775
APO-ALENDRONATE 5MG TABLET Discontinued 2019-01-03 2019-12-21 71023
BISACODYL 5MG TABLET (DELAYED-RELEASE) Discontinued 2019-01-03 2019-01-03 71090
APO-SOLIFENACIN 5MG TABLET Discontinued 2019-03-11 2019-09-20 78272
APO-PINDOL TAB 5MG 5MG TABLET Discontinued 2022-02-09 2022-02-10 154568
APO-CAPTO TAB 6.25MG 6.25MG TABLET Discontinued 2018-09-07 2019-06-12 60339
APO-CARVEDILOL 6.25MG TABLET To be discontinued 2024-01-26 2024-01-26 217499
APO-GEMFIBROZIL 600MG TABLET Discontinued 2017-03-31 2017-03-31 4927
APO-ATOMOXETINE 60MG CAPSULE Discontinued 2018-09-07 2018-09-15 60273
APO-BOSENTAN 62.5MG TABLET Discontinued 2019-01-04 2019-01-04 71339
APO-BROMAZEPAM 6MG TABLET Discontinued 2018-09-07 2018-10-19 60310
APO-HYDROMORPHONE CR 6MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110959
APO-MELOXICAM 7.5MG TABLET Discontinued 2018-09-07 2018-09-15 60612
APO-CIPROFLOX 750MG TABLET Discontinued 2018-09-07 2018-12-28 60388
APO-FENTANYL MATRIX 75MCG PATCH Discontinued 2018-09-07 2018-09-15 60497

Showing 321 to 340 of 356